| CT (n = 32) | MHD (n = 44) | Controls (n = 70) | P value |
---|---|---|---|---|
Age(Years) | 9.14 ± 7.59 | 10.62 ± 3.49 | 10.7 ± 4.51 | 0.14 |
Gender (M/F) | 15 (46.88%)/17(53.12%) | 24(54.55%)/20(45.45%) | 40(57.14%)/30(42.86%) | 0.30 |
BMI (kg/m 2 ) | 17.64 ± 1.17 | 18.89 ± 3.00 | 20.60 ± 1.44 | 0.71 |
SBP (mmHg) | 98.66 ± 6.66 | 125.13 ± 16.36 b* | 95.54 ± 9.70 | 0.01 |
Indexed SBP | 0.90 ± 0.85 | 1.04 ± 0.14 b** | 0.73 ± 0.05 | 0.001 |
DBP (mmHg) | 64.66 ± 6.67 | 83.13 ± 12.76 b* | 61.55 ± 10.10 | 0.01 |
Indexed DBP | 0.90 ± 0.0.86 | 1.00 ± 0.10 b** | 0.72 ± 0.05 | 0.001 |
Creatinine (mg/dl) | 3.93 ± 3.75 a* | 6.30 ± 1.45 b** | 0.73 ± 0.33 | 0.002 |
Predialysis urea, (mg/dl) | 51.12 ± 10.45 a* | 70.56 ± 19.61 b* | 7.76 ± 2.53 | 0.02 |
e-GFR, ml/min/1/1.73 m2 | 15.41 ± 1.76 a** | 11.30 ± 3.35 b** | 86 ± 8.8 | 0.003 |
Dialysis, Yrs |  | 2.73 ± 1.58 |  |  |
Kt/V |  | 1.68 ± 0.40 |  |  |
Total cholesterol (mg/dl) | 164.44 ± 50.10ac** | 192.04 ± 50.37 b* | 161.31 ± 18.75 | 0.06 |
Triglycerides (mg/dl) | 160.78 ± 57.33 a** | 146.00 ± 65.98 b** | 63.31 ± 17.35 | 0.001 |
HDL- cholesterol (mg/dl) | 21.35 ± 1.17a* | 27.33 ± 9.87 b* | 40.55 ± 7.83 | 0.01 |
hs-CRP (mg/dl) | 3.04 ± 3.24 | 3.62 ± 3.97 b* | 1.35 ± 0.65 | 0.04 |
CK-MB (ng/ml) | 6.23 ± 2.46 a* | 5.26 ± 1.14 | 4.20 ± 0.20 | 0.04 |
ACE-activity(IU/l) | 53.02 ± 22.44 | 70.47 ± 53.73 b** | 30.11 ± 8.85 | 0.03 |
Left ventricular mass index (g/m 2.7 ) | 49 ± 5.20 a* | 52.86 ± 10.10 b* | 35.10 ± 8.12 | 0.04 |
Severe left ventricular hypertrophy, n (%) | 6(18.75%) | 25(56.82%) | Â | Â |